Neurotech International Limited announced the appointment of Dr. Alexandra Andrews as Chief Executive Officer, effective from 8 March 2022. She brings expertise in corporate development, investor engagement, product development and commercialisation, clinical trials and regulatory environments. Previously, she was Director of Operations at NeuroScientific Biopharmaceuticals Ltd. Throughout her career, Dr. Andrews has worked closely with clinical researchers, investors and entrepreneurs, providing scientific and strategic input into clinical development plans and overseeing manufacturing.

She brings commercial, transactional and project management experience, including via her earlier role at Linear Clinical Research where she focused on attracting partnerships with US biotechnology and pharmaceutical companies, and managing trial logistics.